Expression of DNA double-strand break repair proteins ATM and BRCA1 predicts survival in colorectal cancer

Clinical Cancer Research

Volumn 12, Issue 5, 2006, Pages 1494-1500

  Grabsch, Heike ^a   Dattani, Mit ^a   Barker, Lisa ^b   Maughan, Nicola ^b   Maude, Karen ^a   Hansen, Olaf ^c   Gabbert, Helmut E ^d   Quirke, Phil ^a   Mueller, Wolfram ^e,f  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c MARIEN HOSPITAL DÜSSELDORF   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e Gemeinschaftspraxis Pathologie   (Germany)

^f Gemeinschaftspraxis Pathologie Starnberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA REPAIR; DNA STRAND BREAKAGE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; ATAXIA TELANGIECTASIA; BRCA1 PROTEIN; BRCA2 PROTEIN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; COLON; COLORECTAL NEOPLASMS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEAR PROTEINS; PILOT PROJECTS; PROTEIN-SERINE-THREONINE KINASES; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 33645068855     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2105     Document Type: Article

References (47)

1. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 2003;3:695-701.
2. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
3. Yamamoto H, Imai K, Perucho M. Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J Gastroenterol 2002;37:153-63.
4. Kolodner RD, Putnam CD, Myung K. Maintenance of genome stability in Saccharomyces cerevisiae. Science 2002;297:552-7.
5. van Gent DC, Hoeijmakers JHJ, Kanaar R. Chromosomal stability and the DNA double-strand break connection. Nat Rev Genet 2001;2:196-206.
6. Zhou B-BS, Iledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433-9.
7. Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 2003;194:77-95.
8. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002;23:687-96.
9. Lees-Miller SP, Meek K. Repair of DNA double strand breaks by nonhomologous end joining. Biochimie 2003;85:1161-73.
10. Wyman C, Ristic D, Kanaar R. Homologous recombination-mediated double-strand break repair. DNA Repair 2004;3:827-33.
11. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-68.
12. Moynahan ME. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 2002;21:8994-9007.
13. Spring K, Ahangari F, Scott SP, et al. Mice heterozygous for mutation in ATM, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 2002;32:185-90.
14. Difilippantonio MJ, Zhu J, Chen HT, et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000;404:510-4.
15. Ouyang H, Nussenzweig A, Kurimasa A, et al. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination in vivo. J Exp Med 1997;186:921-9.
16. Breast Cancer Linkage Consortium T. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999;91:1310-6.
17. Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001;68:700-10.
18. Thompson D, Easton DF. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002;94:1358-65.
19. Brose MS, Rebbeck TR, Calzone KA, et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002;94:1365-72.
20. Niell BL, Rennen G, Bonner JD, et al. BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst 2004;96:15-21.
21. Kirchhoff T, Satagopan JM, Kauff ND, et al. Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. J Natl Cancer Inst 2004;96:68-70.
22. Garcia JM, Rodriguez R, Dominguez G, et al. Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer. Gut 2003;52:1756-63.
23. Uhrhammer N, Bay J, Pernin D, et al. Loss of heterozygosity at the ATM locus in colorectal carcinoma. Oncol Rep 1999;6:655-8.
24. Connolly KC, Gabra H, Millwater CJ, et al. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer. Cancer Res 1999;59:2806-9.
25. Sugai T, Habano W, Uesugi N, et al. Frequent allelic imbalance at the ATM locus in DNA multiploid colorectal carcinomas. Oncogene 2001;20:6095-101.
26. Bai AHC, Tong JHM, To K-F, et al. Promoterhypermethylation of tumor-related genes in the progression of colorectal neoplasia. Int J Cancer 2004;112:846-53.
27. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70.
28. Rigas B, Borgo S, Elhosseiny A, et al. Decreased expression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis. Cancer Res 2001;61:8381-4.
29. Hosoi Y, Watanabe T, Nakagawa K, et al. Upregulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 2004;25:461-8.
30. Komuro Y, Watanabe T, Hosoi Y, et al. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer 2002;95:1199-205.
31. International Union Against Cancer. TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss; 1997.
32. WHO classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC; 2000.
33. Simon R, Mirlacher M, Sauter G. Tissue microarrays. BioTechniques 2004;36:98-105.
34. Grabsch HI, Askham JM, Morrison EE, et al. Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability. J Pathol 2004;202:208-14.
35. Muller W, Schneiders A, Meier S, Hommel G, Gabbert H. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma. Br J Cancer 1996;74:759-65.
36. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
37. Cox D. Regression models and life-tables. J R Stat Soc 1972;34:187-220.
38. Allen C, Halbrook J, Nickoloff JA. Interactive competition between homologous recombination and non-homologous end joining. Mol Cancer Res 2003;1:913-20.
39. Bernard-Gallon D, Peffault de Latour M, Hizel C, et al. Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosas. Anticancer Res 2001;21:2011-20.
40. Garcia V, Garcia JM, Pena C, et al. The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas. J Pathol 2005;206:92-9.
41. Romagnolo DF, Chirnomas RB, Ku J, et al. Deoxycholate, an endogenous tumour promoter and DNA damaging agent, modulates BRCA1 expression in apoptosis-sensitive epithelial cells: loss of BRCA1 expression in colonic adenocarcinomas. Nutr Cancer 2003;46:82-92.
42. Kim N-G, Choi YR, Baek MJ, et al. Frameshift mutations at coding mononucleotide repeats of the MRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res 2001;61:36-8.
43. Ejima Y, Yang L, Sasaki MS. Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: a novel mutation target of microsatellite instability. Int J Cancer 2000;86:262-8.
44. Li H-R, Shagisultanova EI, Yamashita K, et al. Hypersensitivity of tumor cell lines with microsatellite instability to DNA double strand break producing chemotherapeutic agent bleomycin. Cancer Res 2004;64:4760-7.
45. Wang Y, Cortez D, Yazdi P, et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000;14:927-39.
46. Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. The role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst 2004;96:1659-68.
47. Connell PP, Kron SJ, Weichselbaum RR. Relevance and irrelevance of DNA damage response to radiotherapy. DNA Repair 2004;3:1245-51.